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ABSTRACT
Górski K., Hasiec M., Zielińska-Górska M., Fülöp F., Misztal T. (2017):  Up-regulation of oxytocin receptor 
gene and protein in the sheep anterior pituitary by a dopamine derivative (salsolinol). Czech J. Anim. 
Sci., 62, 150−156.
Specific oxytocin receptors (OTR) have been identified in the anterior pituitary (AP), and their expression has 
been shown to change in relation to the animal physiological stage, whereas salsolinol (a derivative of dopamine) 
has been shown to stimulate the synthesis and release of oxytocin (OT) in lactating sheep. In the present study, 
the expression of both OTR mRNA and OTR protein in the AP were examined by real-time quantitative PCR and 
enzyme-linked immunosorbent assay, either in anestrous or lactating sheep 48 h after weaning lambs. Moreover, 
the effect of salsolinol administered via an intracerebroventricular (i.c.v.) infusion was tested in additional sheep 
at the same physiological stages. The i.c.v. infusions of Ringer-Locke (control) and salsolinol solutions were car-
ried out from 10:00 to 15:00 h in a serial manner, i.e. five 30-min infusions at 30-min intervals. We observed both 
OTR gene and OTR protein expression in the AP, in both anestrous and lactating sheep, but it was significantly 
(P < 0.01 and P < 0.05, respectively) higher in the AP of lactating animals compared to anestrous animals. Sal-
solinol i.c.v. treatment in anestrous sheep evoked a significant (P < 0.05) increase in both OTR gene and OTR 
protein expression compared to control animals. In contrast, salsolinol did not affect either OTR gene or OTR 
protein expression in lactating sheep. In conclusion, the expression of OTR in the sheep AP is upregulated by 
salsolinol. The effect of salsolinol was more pronounced in non-lactating sheep, with a reduced response due to 
ongoing OTR expression in lactating animals. Increased expression of OTR in the AP of lactating sheep may be 
related to the stimulation of pituitary lactotrophs by OT following the release of prolactin during suckling.
Keywords: oxytocin; sheep; lactation
The peptide oxytocin (OT) is synthesized in the 
magnocellular neurosecretory cells of the hypotha-
lamic supraoptic (SON) and paraventricular (PVN) 
nuclei, and is stored in the axon terminals located 
in the posterior pituitary (Gimpl and Fahrenholz 
2001; Bealer et al. 2010; Kochman 2013). Activa-
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tion of these hypothalamic neurons leads to OT 
release into the circulation where it is transported 
to different peripheral tissues (Gimpl and Fahren-
holz 2001). OT released from centrally projecting 
oxytocinergic neurons forms the active pool of 
the hormone in the brain (Sabatier et al. 2007). 
Its actions are mediated by a specific oxytocin 
receptor (OTR), which is a G protein-coupled 
receptor. OT has been extensively studied for its 
numerous peripheral and central functions; the 
most well-known are inducing uterine contrac-
tions during parturition and milk ejection during 
lactation, as well as its effects on sexual, feeding, 
maternal, and social behaviours. Indeed, released 
under the influence of suckling stimulus, OT is 
essential for the milk ejection reflex, as it acts on 
myoepithelial cells of the alveoli to induce the 
movement of milk from the place of storage to 
the nipple (Marnet et al. 1998).
Evidence exists that OTR are present in the 
anterior pituitary (AP), and their expression in-
creases during gestation (Breton et al. 1995; Zingg 
and Laporte 2003). One of the best documented 
OT actions in this tissue is the stimulation of 
prolactin (PRL) release (Samson and Schell 1995; 
Kennett and McKee 2012). During lactation, the 
OT surge induced by suckling is accompanied by 
a PRL surge (Kennett and McKee 2012). Kennett 
et al. (2009) have shown that intravenous admin-
istration of an OT antagonist attenuates the PRL 
surge induced by the suckling stimulus.
In recent years, salsolinol (1-methyl-6,7-dihy-
droxy-1,2,3,4-tetrahydroisoquinoline) has emerged 
as an important neural factor regulating the hor-
mones involved in lactation. As a dopamine deri-
vate, salsolinol has been generally associated with 
dysfunction of dopaminergic neurons, though 
presently it is also considered to be a physiologi-
cal stimulator of PRL release in rodents (Toth et 
al. 2001) and ruminants (Hashizume et al. 2008; 
Misztal et al. 2008). In lactating sheep, the suck-
ling stimulus increases the extracellular content 
of salsolinol in the infundibular nucleus-median 
eminence, simultaneously with PRL release into 
the peripheral circulation (Misztal et al. 2008). 
Intracerebroventricular (i.c.v.) infusion of salsolinol 
increases PRL release (Gorski et al. 2010), and 
stimulates PRL gene expression in the AP of lactat-
ing sheep (Hasiec et al. 2012). Moreover, an i.c.v. 
infusion of a salsolinol analogue, 1-methyl-3,4-di-
hydroisoqinoline (1-MeDIQ) in sheep reduces basal 
PRL release and attenuates the suckling-induced 
PRL surge (Gorski et al. 2010; Misztal et al. 2010). 
Our recent studies have shown that salsolinol may 
also be an OT stimulating factor during lactation. 
Salsolinol, when i.c.v. administered in lactating 
sheep, upregulated OT gene expression in the 
PVN and SON, increased OT peptide content in 
the posterior pituitary, and stimulated OT release 
into the peripheral circulation (Gorski et al. 2016).
To further extend our research on the relationship 
between salsolinol and OT, in the present study, 
we have determined the changes in OTR gene and 
protein expression in the AP by comparing an-
estrous and lactating sheep. Additionally, we have 
investigated the effect of salsolinol administered 
via i.c.v. infusion on OTR expression.
MATERIAL AND METHODS
Animal management. All experimental pro-
cedures were conducted in accordance with the 
Polish Guide for the Care and Use of Animals 
and approved by the Local Ethics Committee. 
The experiment was performed on two groups of 
Polish Longwool sheep: Group 1, anestrous sheep 
(n = 12), and Group 2, lactating sheep, 48 h after 
the weaning of 8-week-old lambs (n = 12). Sheep 
in Group 2 were mated naturally in September 
and lambed during the following February. All 
animals were maintained indoors in individual 
pens under natural lighting conditions (52°N, 
21°E). They were fed twice a day a diet formulated 
for non-pregnant or pregnant and lactating sheep, 
according to the recommendations of the National 
Research Institute of Animal Production, Krakow, 
Poland (1993 norms), hay and water were avail-
able ad libitum. Sheep were well-adapted to the 
experimental conditions, and always had visual 
contact with neighbouring sheep, even during the 
experimental period, to prevent stress as a result 
of social isolation.
Brain surgery. Anestrous and pregnant (third 
month of pregnancy) sheep were implanted with 
a stainless steel guide cannula (outer diameter 
1.4 mm) into the third ventricle of the brain. The 
implantation was performed under general an-
esthesia (a mixture of xylazine 40 mg/kg body 
weight, and xylapan and ketamine 10–20 mg/kg 
body weight, administered intravenously; all Bio-
wet, Poland), through a drill hole in the skull, in 
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accordance with the stereotactic coordinate system 
for the sheep hypothalamus (Welento et al. 1969), 
using the procedure described by Traczyk and 
Przekop (1963). The guide cannulae were fixed 
to the skull with stainless steel screws and dental 
cement Villacryl S (Zhermapol, Poland). The ex-
ternal opening of the cannula was closed with a 
stainless steel cap. The placement of the cannula 
was confirmed during surgery by the outflow of 
the cerebrospinal fluid, and postmortem by the 
injection of blue ink.
Drug treatment and experimental design. Sal-
solinol was synthesized and kindly provided by Prof. 
Ferenc Fülöp from the Institute of Pharmaceuti-
cal Chemistry, Faculty of Pharmacy, University 
of Szeged, Hungary. It was dissolved in Ringer-
Locke’s solution (RL), then aliquoted and stored 
at –20°C. A new aliquot of the drug solution was 
used for each infusion to maintain the biological 
activity of the molecules during the experiment.
Both anestrous and lactating sheep were ran-
domly divided into two groups: control (2 × n = 6) 
and experimental (2 × n = 6), and were given an 
i.c.v. infusion of RL or salsolinol solution, re-
spectively. The infusions were carried out from 
10:00 to 15:00 h in a serial manner (five 30-min 
infusions at 30-min intervals) using a BAS Bee™ 
microinjection pump and calibrated 1.0-ml gas-
tight syringes (Bioanalytical Systems Inc., USA). 
The salsolinol dosage (5 × 15 μg/60 μl/30 min) was 
selected based on our previous studies (Gorski 
et al. 2010; Hasiec et al. 2012). Immediately after 
the end of the experiment (15:00 h) sheep were 
deeply anaesthetized with sodium pentobarbital 
(30 mg/kg body weight; Biowet) and euthanized 
by decapitation. The AP was rapidly dissected, 
immediately flash frozen in liquid nitrogen, and 
stored at –80°C until assayed.
Gene expression assay. Tissue samples were ho-
mogenized using a TissueLyser LT bead mill (Qiagen, 
Germany). Total RNA was extracted and purified 
using a NucleoSpin RNA II kit (Macherey-Nagel 
GmbH & Co., Germany) with on-column DNase 
treatment, in accordance with the manufacturer’s 
instructions. The total RNA concentration and 
purity were measured using a NanoDrop ND-1000 
spectrophotometer (Thermo Fisher Scientific, 
USA). Sample integrity was assessed electropho-
retically using ethidium bromide-stained 1.5% 
agarose gels. Total RNA (1 g in a volume of 20 l) 
was reverse-transcribed into first-strand cDNA 
using a Maxima First Strand cDNA Synthesis Kit 
(Thermo Fisher Scientific) in accordance with the 
manufacturer’s instructions.
Relative amounts of specific OTR transcripts were 
determined by real-time quantitative PCR (qPCR) 
analysis, using a Rotor-Gene Q cycler (Qiagen). 
OTR mRNA analysis was performed using the 
Luminaris HiGreen qPCR Master Mix (Thermo 
Fisher Scientific) and HPLC-grade oligonucleotide 
primers (Genomed, Poland). Specific primers for 
determining the expression of the gene of interest 
and endogenous control genes were designed with 
Primer3 software (Untergasser et al. 2012). The 
qPCR reactions were run in triplicate using the 
following protocol: initial denaturation and enzyme 
activation at 95°C for 15 min, followed by 35 cycles 
of denaturation at 95°C for 15 s, annealing at 56°C 
for 20 s, and extension at 72°C for 20 s. After the 
cycles, a final melting curve analysis with continu-
ous ﬂuorescence measurements was performed 
to confirm the specificity of the amplification. To 
confirm that single amplification products were 
produced, samples were stained with ethidium bro-
mide and electrophoresed on an agarose gel before 
visualization under a UV light camera. The OTR 
mRNA levels were normalized to the endogenous 
control gene, glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH). Initially, three housekeeping 
genes – GAPDH, β-actin (ACTB), and tyrosine 
3-monooxygenase/tryptophan 5-monooxygenase 
activation protein zeta (YWHAZ) – were tested. 
The BestKeeper software (Pfaffl et al. 2004) was 
used to determine the most stable housekeeping 
gene for normalizing the expression of genes of 
interest. All primers are listed in Table 1.
ELISA protein quantification. Frozen AP was 
homogenized in ice cold phosphate-buffered saline 
(pH 7.4) (Sigma-Aldrich, USA) using the TissueLys-
er LT bead mill. Afterwards, samples were frozen 
at –20°C and stored overnight. After two freeze-
thaw cycles, the homogenates were centrifuged at 
5000 g for 5 min at 4°C, then supernatant fluids 
were removed and assayed immediately. The con-
centration of OTR protein in the AP extracts was 
determined with a commercial ELISA kit (Sheep 
OTR ELISA Kit; Mybiosource, USA). The assay 
sensitivity was 0.094 ng/ml, and both intra- and 
inter-assay variability was 10%. The absorbance 
measurement at 450 nm was performed using a 
Spectramax M2 microplate reader (Molecular 
Devices LLC, USA). The obtained results were 
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normalized to the total protein concentration 
in samples, assayed with the Bradford reagent 
(Sigma-Aldrich).
Data analysis. RotorGene Q software (Qiagen) 
was used to generate and collate the qPCR data. 
The relative gene expression was determined us-
ing the Relative Expression Software Tool 2008 
(Qiagen). The results are presented as the relative 
gene expression of the target gene compared with 
the endogenous control gene. The average relative 
quantity of gene expression in the control group 
was set to 1.0.
The non-parametric Mann-Whitney U test was 
used to assess the significance of the differences in 
OTR mRNA and OTR protein expression between 
the experimental and control groups. Calculations 
were performed using STATISTICA software (Ver-
sion 10). All data are expressed as mean ± SEM.
RESULTS
The analyses revealed the presence of specific 
OTR transcripts and OTR protein in the AP of 
both anestrous and lactating sheep. OTR mRNA 
expression was up-regulated (P < 0.001) in lactat-
ing sheep when compared to the AP of anestrous 
sheep (Figure 1A). Similarly, the OTR protein 
content in the AP of lactating sheep was increased 
(P < 0.05) compared to the levels in anestrous 
animals (Figure 1B).
Salsolinol infused into the third ventricle of the 
brain up-regulated (P < 0.01) OTR mRNA expres-
sion in the AP of anestrous sheep. However, in 
lactating sheep, treatment with salsolinol was 
ineffective (Figure 1A). Salsolinol administered via 
i.c.v. infusion also evoked a significant (P < 0.05) 
increase in the OTR protein content in the AP of 
Table 1. Sequences of the primers used in the qPCR analysis
Gene GenBank Acc. No. Primer sequence
OTR NM_001009752 F: TCAGCAACGTCAAGCTCATCR: TCCACATCTGCACGAAAAA
GAPDH NM_001034034 F: AGAAGGCTGGGGCTCACTR: GGCATTGCTGACAATCTTGA
ACTB NM_001009784 F: CTTCCTTCCTGGGCATGG
R: GGGCAGTGATCTCTTTCTGC
YWHAZ NM_001267887 F: AGACGGAAGGTGCTGAGAAAR: GAAGCGTTTGGGATCAAGAA
F = forward primer, R = reverse primer
Figure 1. Relative oxytocin receptor (OTR) mRNA expression (A) and oxytocin receptor (OTR) polypeptide expres-
sion (B) in the anterior pituitary of anestrous sheep (n = 12) and lactating sheep (n = 12) infused with vehicle (control; 
white bars) or salsolinol (grey bars). Data are presented as mean ± SEM
**P < 0.01, *P < 0.05 according to the non-parametric Mann-Whitney U test
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anestrous sheep, while in lactating animals, OTR 
protein expression was not significantly changed 
in response to salsolinol (Figure 1B).
DISCUSSION
The present study demonstrates the variations in 
OTR gene expression and OTR protein concentra-
tions in the sheep AP, which were higher during 
lactation than in seasonal anestrus. Moreover, the 
dopamine derivative salsolinol, which is a stimula-
tory agent for the release of both PRL (Gorski et 
al. 2010) and OT (Gorski et al. 2016) in lactating 
sheep, also up-regulated the OTR contents in the 
AP, which were higher during lactation than dur-
ing seasonal anestrus.
The central sites of OT synthesis are localized in 
the hypothalamic PVN and SON. Although most 
of OT neurons project into the posterior pituitary, 
where the neurohormone is stored and released 
into the circulation, OT also reaches the anterior 
pituitary through the short portal vessels connect-
ing these two parts (Gibbs 1984; Samson and Schell 
1995). Additionally, magnocellular oxytocinergic 
neurons innervate the median eminence, where 
they can act on the anterior pituitary (Yang et al. 
2013). OTR immunoreactivity was found in the rat 
AP (Adan et al. 1995), and early studies showed 
that most OTR are present in lactotrophic cells 
(Breton et al. 1995) where OT plays an important 
role in stimulating PRL secretion (Samson et al. 
1986). In addition, OT is involved in stimulating 
ACTH release from rat pituitary cells (Schlosser 
et al. 1994), and the OTR gene has also been found 
in mouse AP corticotrophs (Nakamura et al. 2008). 
Recently, Gonzales-Iglesias et al. (2015) provided 
evidence that gonadotrophs and somatotrophs, 
in addition to lactotrophs, are sensitive to OT 
stimulation, and responded with transient eleva-
tions in the intracellular Ca2+ concentration and 
hormone release in a dose-dependent manner. 
These responses were also evoked by an OTR 
agonist, and abolished by an OTR antagonist, sug-
gesting that the OT-induced effects are mediated 
by OTRs in all three cell types (Gonzalez-Iglesias 
et al. 2015). It has been suggested that OT may act 
directly on different AP cell types to coordinate 
hormone release.
The increased OTR expression in the AP dur-
ing lactation seen in our study may mediate the 
biochemical adaptations of the pituitary cells, 
especially lactotrophs, to facilitate an increase in 
the PRL synthesis and secretion. Several groups 
have identified the ability of OT to act directly on 
AP lactotrophs to release PRL (Samson and Schell 
1995; McKee et al. 2007; Tabak et al. 2010). McKee 
et al. (2007) demonstrated that OT action at the 
lactotroph is required for PRL surges in cervically 
stimulated ovariectomized rats. According to Sam-
son et al. (1986), the OT surge precedes that of PRL 
in response to suckling. Moreover, attenuation of 
OT action by the administration of a selective OT 
antagonist (desGly-NH2-d(CH2)5[D-Tyr2,Thr4]
OVT) is able to block the suckling-induced PRL 
surge (Kennett et al. 2009). These data further 
support the thesis that OT stimulates PRL release 
from AP lactotrophs, and underline the importance 
of this phenomenon for lactation.
The salsolinol stimulatory effect on both OTR 
mRNA and OTR protein expression in the sheep 
AP was shown for the first time in this study, and 
extends our research. Interestingly, OTR mRNA 
levels as well as protein contents reached similar 
values in anestrous sheep as those seen in lactating 
animals. Although salsolinol was not detected in 
seasonally anestrous sheep (Misztal et al. 2008), 
the increase in OTR in the pituitary cells as a result 
of salsolinol treatment may indicate their prepar-
edness for the signals associated with lactation. 
In turn, salsolinol administered via i.c.v. infusion 
in lactating sheep only slightly enhanced OTR 
mRNA expression. We assume that the level of 
OTR expression during lactation is so high that ad-
ditional stimulating factors cannot evoke a further 
increase in expression. In contrast, a significant 
upregulation of PRL mRNA expression in the AP 
after i.c.v. treatment with salsolinol was evident 
48 h after lamb separation (Hasiec et al. 2012).
Based on available data, the proper mechanism of 
salsolinol action on OTR expression is difficult to 
determine. Although a specific salsolinol receptor 
has not been identified, high-affinity binding sites 
for salsolinol have been detected in the median 
eminence, hypothalamus, and AP (Toth et al. 2001; 
Homicsko et al. 2003). It has also been shown that 
OTRs are highly upregulated during parturition and 
lactation. Gonadal steroids are thought to be the 
key factors mediating this regulation. In the AP, a 
marked increase in OTR expression was observed 
after estrogen treatment in ovariectomized female 
rats (Breton and Zingg 1997; Quinones-Jenab et 
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al. 1997). The OTR promoter sequence contains 
elements of the estrogen response element (ERE); 
however, it is not a completely functional ERE 
(Gimpl and Fahrenholz 2001). Estrogen modulation 
probably involves additional factors, and might be 
mediated via other functional promoter elements 
(Zingg and Laporte 2003). The sequence analysis 
of the rat OTR gene revealed the presence of cAMP 
response elements (CRE). Some data suggest that 
cAMP may induce the up-regulation of OTR gene 
expression. Treatment with forskolin, a compound 
that elevates the intracellular cAMP concentration, 
increases OT binding and OTR mRNA expression 
in rabbit amnion cells in vitro ( Jeng and Soloff 
2009). Additionally, dibutyryl-cAMP has been 
shown to increase OTR gene expression in vitro 
(Ivell et al. 2001). In turn, salsolinol has been shown 
to be a stimulator of cAMP accumulation in the 
AP (Radnai et al. 2005). Regarding these data, it 
is assumed that salsolinol may induce OTR gene 
expression in pituitary cells via the activation of 
intracellular cAMP. Further studies are required, 
especially concerning the identification of specific 
salsolinol receptors and the intracellular mecha-
nism of its action.
In conclusion, the expression of OTR in the 
sheep AP is upregulated by salsolinol. The effect 
of salsolinol may be more pronounced in non-
lactating sheep, with a less robust response ob-
served with ongoing OTR expression in lactating 
animals. The increased OTR expression in the AP 
of lactating sheep may be related to the stimulation 
of pituitary lactotrophs by OT and the release of 
PRL during suckling.
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